Landmark Study Reveals Weight Loss Jabs are Not a Quick Fix for Obesity
A new study published in the BMJ has found that individuals who stop taking weight loss medications, known as GLP-1 agonists, regain an average of 4.8kg within just one year and return to their original weight within 1.7 years after treatment has ended.
Conducted by researchers at the University of Oxford, the study analyzed data from over 9,300 participants across 37 existing studies, with a total duration of 39 weeks for treatment and 32 weeks of follow-up. The findings show that weight loss medications can achieve impressive results, but this rapid regaining of weight after stopping treatment is significantly faster than those using behavioral programs.
According to Dr Sam West, lead researcher, the high rate of weight regain "reflects the nature of obesity as a chronic, relapsing condition." He emphasized that these medicines are not a quick fix and can achieve significant weight loss but require long-term management with comprehensive support. This includes adopting healthier diets and increased physical activity.
The study highlights the importance of primary prevention over short-term treatment with these medications. Dr Faye Riley from Diabetes UK noted, "Weight loss drugs can be effective tools for managing weight and type 2 diabetes risk โ but they are not a quick fix." The NHS has taken note, stressing that these treatments must be paired with behavioral support to achieve long-term weight management.
The study also found benefits on cardio-metabolic health markers such as blood pressure and cholesterol levels returning to their original state within 1.4 years of stopping treatment. However, this underscores the need for sustained support beyond just medication.
The Obesity Health Alliance's Katharine Jenner pointed out that regaining weight after stopping treatment is not a failure of individuals but rather "reflects the reality of living in a food environment that continually pushes people towards unhealthy options."
As the study emphasizes the importance of long-term support and comprehensive management, health experts emphasize the need for innovative solutions to address obesity's complex nature.
A new study published in the BMJ has found that individuals who stop taking weight loss medications, known as GLP-1 agonists, regain an average of 4.8kg within just one year and return to their original weight within 1.7 years after treatment has ended.
Conducted by researchers at the University of Oxford, the study analyzed data from over 9,300 participants across 37 existing studies, with a total duration of 39 weeks for treatment and 32 weeks of follow-up. The findings show that weight loss medications can achieve impressive results, but this rapid regaining of weight after stopping treatment is significantly faster than those using behavioral programs.
According to Dr Sam West, lead researcher, the high rate of weight regain "reflects the nature of obesity as a chronic, relapsing condition." He emphasized that these medicines are not a quick fix and can achieve significant weight loss but require long-term management with comprehensive support. This includes adopting healthier diets and increased physical activity.
The study highlights the importance of primary prevention over short-term treatment with these medications. Dr Faye Riley from Diabetes UK noted, "Weight loss drugs can be effective tools for managing weight and type 2 diabetes risk โ but they are not a quick fix." The NHS has taken note, stressing that these treatments must be paired with behavioral support to achieve long-term weight management.
The study also found benefits on cardio-metabolic health markers such as blood pressure and cholesterol levels returning to their original state within 1.4 years of stopping treatment. However, this underscores the need for sustained support beyond just medication.
The Obesity Health Alliance's Katharine Jenner pointed out that regaining weight after stopping treatment is not a failure of individuals but rather "reflects the reality of living in a food environment that continually pushes people towards unhealthy options."
As the study emphasizes the importance of long-term support and comprehensive management, health experts emphasize the need for innovative solutions to address obesity's complex nature.